Mercado global de medicamentos para a mucosite oral – Tendências do setor e previsão para 2030

Análise e dimensão do mercado de medicamentos para a mucosite oral

Os casos crescentes de cancro de cabeça e pescoço em todo o mundo impulsionam o mercado de medicamentos para a mucosite oral. O aumento das infeções na boca e na cavidade oral, a má higiene oral e o estilo de vida deficiente também impulsionam o crescimento do mercado de medicamentos para a mucosite oral. No entanto, o aumento e o avanço tecnológico contínuo para o diagnóstico e tratamento também estão a impulsionar o crescimento do mercado. No entanto, o tratamento medicamentoso específico não está disponível para a infeção ou doença, e o elevado custo do tratamento pode dificultar o mercado global de medicamentos para a mucosite oral.

A mucosite oral é o sintoma mais comum das complicações debilitantes dos tratamentos do cancro, que decompõem as células epiteliais rapidamente divididas que revestem o tracto gastrointestinal (que vai da boca ao ânus), deixando o tecido da mucosa aberto a ulcerações e infecções. A mucosite oral ocorre principalmente devido à quimioterapia e à radioterapia. Este distúrbio pode levar a problemas de saúde graves, como sangue na boca, feridas na boca (gengivas e língua), dor na boca e na garganta, sensação de secura, ardor ligeiro ou dor ao comer alimentos e outros.                                

A Data Bridge Market Research analisa que o mercado global de medicamentos para a mucosite oral, que foi de 530,00 milhões de dólares em 2023, subiria para 896,62 milhões de dólares até 2030, e deverá passar por um CAGR de 7,80% durante o período de previsão. Isto indica que o valor de mercado. “Induzido pela quimioterapia” domina o segmento de causas do mercado de medicamentos para a mucosite oral devido à crescente prevalência de cancro levando a um aumento da quimioterapia. Além dos insights sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análise especializada aprofundada, epidemiologia de pacientes, análise de pipeline, análise de preços, e quadro regulamentar.

Âmbito e segmentação do mercado de medicamentos para a mucosite oral

Market Definition

Oral mucositis is a common and often painful condition characterized by inflammation and ulceration of the mucous membranes lining the mouth. It is a side effect that can occur as a result of certain cancer treatments, particularly chemotherapy and radiation therapy directed towards the head and neck area.

The oral mucositis drugs market refers to the pharmaceutical sector that focuses on the development, production, and commercialization of medications specifically designed to prevent or treat oral mucositis. These drugs are intended to alleviate the symptoms and reduce the severity of oral mucositis, such as pain, inflammation, and ulceration of the oral mucosa. The market includes various types of drugs, including topical gels, mouth rinses, oral sprays, and systemic medications, that are prescribed to patients undergoing cancer treatments, such as chemotherapy and radiation therapy, which often cause oral mucositis as a side effect. The goal of the oral mucositis drugs market is to provide effective treatment options that improve the quality of life for patients experiencing this debilitating condition.

Global Oral Mucositis Drugs Market Dynamics

Drivers

• Increasing Incidence of Cancer

The rising prevalence of cancer worldwide, particularly head and neck cancers, drives the demand for oral mucositis drugs. Chemotherapy and radiation therapy, commonly used treatments for cancer, often result in oral mucositis as a side effect, necessitating the need for effective medications.

• Growing Awareness and Diagnosis

There is a growing awareness among healthcare professionals regarding the impact of oral mucositis on patients undergoing cancer treatment. Improved understanding and early diagnosis of oral mucositis lead to increased demand for drugs that can alleviate symptoms and improve patient comfort.

• Increasing Focus on Personalized Medicine

The growing trend toward personalized medicine in oncology has extended to oral mucositis treatment. Tailored approaches that consider individual patient characteristics and cancer treatments drive the development of targeted oral mucositis drugs, providing more effective and personalized care.  

Opportunities

• Technological Advancements and Medical Innovations

Advances in medical research and technology have led to the development of novel therapeutic approaches and drug formulations for oral mucositis treatment. These innovations include the introduction of new drug classes, improved drug delivery systems, and targeted therapies, enhancing the effectiveness and safety of oral mucositis drugs.

Restraints/Challenges

• High Development Costs

The research, development, and clinical trial costs associated with bringing oral mucositis drug to market can be substantial. The extensive investment required, coupled with the risk of failure during the development process, can deter some pharmaceutical companies from pursuing research in this field. High development costs may limit the number of new drugs entering the market and potentially slow down innovation.

This Oral mucositis drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Oral mucositis drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• March 2023, EVERSANA, a leading provider of commercialization services to the life science industry, announced a partnership with ChemoMouthpiece, LLC, to support the launch and commercialization of its medical device, the Chemo Mouthpiece™, to help cancer patients manage and treat oral mucositis in oncology patients across the United States.

Global Oral mucositis drugs Market Scope

The oral mucositis drugs market is segmented on the basis of causes, drugs class, drugs, dosage form, end users and distribution channel. The growth amongst these segments will help you meagre growth segments in the industries and provide the users with a valuable market overview and insights to help them make strategic decisions for identifying core market applications.

Causes

• Chemotherapy-Induced
• Radiotherapy-Induced
• Others

Drugs Class

• Antibiotics
• Antifungal
• Anti-Inflammatory
• Anti-Neoplastic
• Others

Drugs

• Gelclair
• Zilactin
• Ethyol
• Morphine
• MuGard
• Others

Dosage Form

• Ointment
• Solution
• Gel
• Paints
• Others

End User

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

Distribution Channel

• Direct Tender
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Oral mucositis drugs Market Regional Analysis/Insights

The Oral mucositis drugs market is analysed, and market size insights and trends are provided by country, causes, drugs class, drugs, dosage form, end-users and distribution channel as referenced above.

The countries covered in the Oral mucositis drugs market report is U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E, Egypt, Israel, Rest of Middle East & Africa.

North America is expected to dominate the global oral mucositis drugs market due to the increasing prevalence of cancer in that region. And the Asia Pacific is the fastest growing region due to increasing rising awareness and interest in health and wellness.

The country section of the report also provides individual market impacting factors and domestic regulation changes that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The oral mucositis drugs market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kind of products for the oral mucositis drugs market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the oral mucositis drugs market. The data is available for the historic period 2015-2020.

Competitive Landscape and Oral mucositis drugs Market Share Analysis

O panorama competitivo do mercado de medicamentos para a mucosite oral fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado de medicamentos para a mucosite oral.

Alguns dos principais players que trabalham no mercado de medicamentos para a mucosite oral são:

• AMAG Pharmaceuticals, Inc.
• Access Pharmaceuticals, Inc. (EUA)
• DARA BioSciences (EUA)
• Grupo Helsinn. (Suíça)
• Corporação Farmacêutica Izun. (NÓS)
• Inovação Farmacêutica. (NÓS)
• Shoreline Pharmaceuticals, Inc.
• Companhia Farmacêutica dos Himalaias. (Índia)
• Clinigen Saúde. (Inglaterra)
• Mylan NV (EUA)
• (EUA)
• Sun Indústrias Farmacêuticas, Lda. (Índia)
• (Israel)
• Reddy's Laboratories Ltd (Índia)
• Amneal Pharmaceuticals LLC (EUA)

SKU-57289